Seeing Is Believing
Currently out of the existing stock ratings of David Maris, 55 are a BUY (50.93%), 44 are a HOLD (40.74%), 9 are a SELL (8.33%).
Analyst David Maris, currently employed carries an average stock price target met ratio of 50.06% that have a potential upside of 19.63% achieved within 228 days. Previously, David Maris worked at WELLS FARGO.
David Maris’s has documented 211 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 28-Oct-2021.
Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 11/8/2017. The price target of $22 was fulfilled within 1 day with a profit of $2.02 (10.11%) receiving and performance score of 101.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$193
$-0.02 (-0.01%)
4 years 6 months 30 days ago
(21-Apr-2020)
2/7 (28.57%)
$8.96 (4.87%)
35
Buy
$203
4 years 9 months 3 days ago
(18-Feb-2020)
1/2 (50%)
$20.22 (11.61%)
95
Hold
$203
$9.98 (5.17%)
$178
4 years 9 months 10 days ago
(10-Feb-2020)
6/19 (31.58%)
$3.35 (1.68%)
69
Buy
$247
5 years 3 months 13 days ago
(07-Aug-2019)
0/4 (0%)
$88.31 (55.65%)
Hold
$157
$-36.02 (-18.66%)
$161
5 years 3 months 13 days ago
(07-Aug-2019)
10/10 (100%)
$-1.84 (-1.16%)
200
What Year was the first public recommendation made by David Maris?